(805) 963-0439 | Toll-Free (800) 876-6425 LA / NY / UK

Cognition Studio, Inc.

Moderna's Personalized Cancer Vaccine (PCV) 

Prev Next

Omega: Epigenomic Programming MOA

Next medical animation of Adaptive Biotechnologies have revolutionized the immunotherapy landscape by allowing doctors and scientists to more precisely measure the number of remaining cancer cells after treatment and track newly emerging cancer cells. This will enable doctors to adjust therapy for greater efficacy. Cognition developed this animation in line with other web content to create a cohesive explanatory MRD platform.

Adaptive: Measurable Residual Disease (MRD)

Using mRNA as a drug, Moderna developed a personalized cancer vaccine (PCV) technology that could rapidly create one medicine for one patient. Cognition created an animation of Moderna’s PCV manufacture and MOA. By including voiceovers from Moderna subject matter experts and crafting a bright, friendly aesthetic, the animation is approachable but does not shy away from explaining the science. Visit to see the case study.

Keywords: Animation, Advertising / Marketing, Editorial, Patient Education, Biotechnology, Cell biology / Histology, Genetics, Molecular Biology, Oncology, Mechanism of Action (MOA)

Moderna Therapeutics